Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients-Reference-Cited by-同舟云学术

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients

Published:2005-03 Issue:3 Volume:128 Page:636-641
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Romero-Gómez Manuel,Del Mar Viloria Maria,Andrade Raúl J.,Salmerón Javier,Diago Moisés,Fernández-Rodríguez Conrado M.,Corpas Raquel,Cruz Marina,Grande Lourdes,Vázquez Luis,Muñoz-de-Rueda Paloma,López-Serrano Pilar,Gila Ana,Gutiérrez María L.,Pérez Celia,Ruiz-Extremera Angela,Suárez Emilio,Castillo Jesús

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference28 articles.

1. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

2. HLA class I B44 is associated with sustained response to interferon + ribavirin therapy in patients with chronic hepatitis C;Romero-Gomez;Am J Gastroenterol,2003

3. Response to interferon therapy;Sim;J Viral Hepat,1998

4. African Americans with genotype 1 treated with interferon for chronic hepatitis C have a lower end of treatment response than Caucasians;Kinzie;J Viral Hepat,2001

5. High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C;Bressler;Hepatology,2003

Cited by 625 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan;Digestive Diseases and Sciences;2024-07-04

2. The benefits of hepatitis C viral eradication: a real-world nationwide cohort study in Taiwan;2024-04-10

3. Lipid Profile and Cardiovascular Risk Modification after Hepatitis C Virus Eradication;Pathogens;2024-03-25

4. Fatty liver and viral hepatitis: Prevalence, risk factors, natural course, pathogenesis, and management;Metabolic Steatotic Liver Disease;2024

5. Circulating hsa-miR-221 as a possible diagnostic and prognostic biomarker of diabetic nephropathy;Molecular Biology Reports;2023-10-13